News

The Ampicillin and Sulbactam product will be sold in 1.5g and 3g single-dose and 15g pharmacy bulk package vials. However, Ampicillin product will be sold in five presentations:

Following FDA’s complete response letter, HGS and Novartis have jointly decided to terminate the development of Zalbin. Zalbin is a genetic fusion of human albumin and interferon alfa

The studies were conducted to evaluate the efficacy and safety of two dosage strengths of RHUCIN, an investigational drug, for the treatment of acute attacks in patients with

Tapentadol is a centrally-acting analgesic with a dual mode of action as an agonist at the µ-opioid receptor and as a norepinephrine reuptake inhibitor. J&JPRD’s NDA was filed

Mayo Clinic Research Informatics associate dean Gloria Petersen said that Mayo’s Clinical Trials Management System (CTMS) will eliminate the duplication, delays and errors caused by manual data entry

The patents cover the various properties of Protectan CBLB612 and related compounds, including composition of matter and methods of use for protecting against apoptosis. Protectan CBLB612 is a

The collaboration will focus on moving the clinical development of Exebryl-1 though the regulatory process in China and the US. Exebryl-1 has been shown to inhibit beta-amyloid protein

The new kits are a combination of Gentel’s APiX chromogenic detection technology and RayBiotech, collection of more than 55 antibody and protein arrays on a glass-slide format and

The PerformCycle platform combines evidence-based care guidelines, the Asthma Action Plan, and post-care patient tracking (CareTracker) solutions to offer home monitoring of a child’s post-care progress and share